Novanta (NASDAQ:NOVT - Get Free Report) issued its quarterly earnings data on Tuesday. The technology company reported $0.74 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.68 by $0.06, Zacks reports. Novanta had a return on equity of 15.20% and a net margin of 6.52%. The business had revenue of $233.37 million for the quarter, compared to analysts' expectations of $233.34 million. During the same quarter in the prior year, the firm posted $0.74 EPS. The firm's quarterly revenue was up 1.1% on a year-over-year basis. Novanta updated its Q2 2025 guidance to 0.680-0.780 EPS.
Novanta Price Performance
Shares of Novanta stock traded up $0.77 during trading on Friday, hitting $122.68. 256,887 shares of the stock traded hands, compared to its average volume of 203,844. The stock has a market cap of $4.41 billion, a price-to-earnings ratio of 73.46 and a beta of 1.51. The company has a quick ratio of 1.81, a current ratio of 2.79 and a debt-to-equity ratio of 0.61. Novanta has a 52 week low of $98.76 and a 52 week high of $187.12. The firm's fifty day moving average is $123.66 and its 200-day moving average is $146.02.
Wall Street Analysts Forecast Growth
Separately, Robert W. Baird cut their price target on shares of Novanta from $169.00 to $160.00 and set a "neutral" rating for the company in a research note on Monday, March 3rd.
View Our Latest Stock Analysis on Novanta
Novanta Company Profile
(
Get Free Report)
Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.
Further Reading

Before you consider Novanta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novanta wasn't on the list.
While Novanta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.